BiotechTube
Home/EnClear Therapies/Tony DePasqua
TD

Tony DePasqua

President & CEO

EnClear Therapies

Therapeutic Areas

Neuro-oncologyNeurodegenerative DiseasesLysosomal Storage DiseasesAutoimmune Diseases

EnClear Therapies Pipeline

DrugIndicationPhase
EnTrega Platform for Leptomeningeal CarcinomatosisLeptomeningeal Carcinomatosis (LC)Pre-clinical

Leadership Team at EnClear Therapies

KK
Kevin Kalish
COO
MG
Marcie Glicksman
VP Biology
WG
William Gormley
CMO
View full EnClear Therapies profile